SEC Form 4 · accession 0001209191-16-141402
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Stejbach
Director
Period of report
Sep 13, 2016
Accepted (ET)
Sep 14, 2016 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $15.87 | Sep 13, 2016 | A | 25,000 | A | — | Sep 12, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1One-third of the shares subject to the option will vest on September 13, 2017 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter.